We’re very pleased to share our latest newsletter for all our participants in The Markers in Neuropsychiatric Disorders Study, with lots of exciting news and updates. We hope you enjoy it, and please get in touch with us any time – we’d love to hear from you!
* However, we will still be accepting referrals from specialists for people with very strongly suspected or diagnosed Alzheimer disease, frontotemporal dementia, or other dementia. We’re extremely grateful for the huge interest and contribution from so many specialists, GPs, patients/participants and their families. We couldn’t have achieved so much in… Read More »Recruitment has now closed*
People with neurological and psychiatric symptoms often experience a delay in getting an accurate diagnosis. Misdiagnosis and uncertainty is common, despite all of our current best assessments and tools. We have found that neurofilament light chain in spinal fluid, a marker of brain cell injury, can help distinguish between neurological… Read More »Our latest publication – neurofilament light in spinal fluid could reduce the misdiagnosis of dementia
Hello again World! We’ve been quiet here, but been working away very busily. We’re very proud to announce our latest pre-print, up now on medRxiv here: https://medrxiv.org/cgi/content/short/2023.02.19.23286151v1 We investigated blood neurofilament light (NfL) in behavioural variant frontotemporal dementia (bvFTD) & psychiatric conditions, which can have overlapping presentations, are frequently challenging… Read More »Our latest pre-print on plasma NfL in bvFTD and psychiatric conditions
Hello and welcome, Tasmania! We’re so pleased and excited to announce that we’re now able to recruit participants from Tassie! Interested in joining our study? Please click here for more info and to get in touch!
Welcome to the first edition of the MiND community newsletter – a communication from the MiND Study Team to keep our participants and community partners and friends informed, updated, and engaged on all things MiND. By studying neurofilament light and other biomarkers, and a range of other markers in a… Read More »Our first MiNDful community newsletter!
The background We know that diagnosis, treatment, and care, for so many people with conditions like dementia, especially younger-onset dementia, is not straightforward. A large part of this challenge is because symptoms, especially early in the illness, can overlap significantly with a range of other conditions. For example, stress, depression,… Read More »where The MiND Study has come from, and where we’re headed
Hello NSW and NT! We’re growing, and we’re so pleased to now welcome participants from NSW and NT, as well as QLD, WA, SA, and VIC! Please spread the word, and get in touch – we’d love to hear from you!
Welcome to MiND MattersThe Markers in Neuropsychiatric Disorders Study NewsletterFestive Issue – December 2021 Welcome to the festive and 2021 wrap up edition of our MiND Matters e-newsletter. What a year it has been! Looking back at 2021, we would like to acknowledge and celebrate our many achievements, despite living through… Read More »2021 wrap up edition of MiND matters newsletter
It’s been a very productive year for disseminating results. In addition to many conference and other meeting posters and presentations, we are very proud to share that several MiND manuscripts have been accepted in 2021. Dr Eratne published two big MiND papers this year. First, “Cerebrospinal fluid neurofilament light chain differentiates… Read More »2021 research wrap up!